Skip to main navigation Skip to search Skip to main content

Plasma vitamins B2, B6, B12, and related genetic variants as predictors of colorectal cancer risk

  • Simone Jpm Eussen
  • , Stein Emil Vollset
  • , Steinar Hustad
  • , Oivind Midttun
  • , Klaus Meyer
  • , Ase Fredriksen
  • , Per M Ueland
  • , Mazda Jenab
  • , Nadia Slimani
  • , Paolo Boffetta
  • , Kim Overvad
  • , Ole Thorlacius-Ussing
  • , Anne M Tjonneland
  • , Anja Olsen
  • , Francoise Clavel-Chapelon
  • , Marie-Christine Boutron-Ruault
  • , Sophie Morois
  • , Cornelia Weikert
  • , Tobias Pishon
  • , Jakob Linseisen
  • Rudolf Kaaks, Antonia Trichopoulou, Demosthenes Zilis, Michael Katsoulis, Domenico Palli, Valeria Pala, Paolo P Vineis, Rosario Tumino, Salvatore Panico, Petra H M Peeters, H Bas Bueno-de-Mesquita, Fränzel van Duijnhoven, Guri Skeie, Xavier Muñoz, Carmen Martínez-García, Miren Dorronsoro, Eva Ardanaz, Carmen Navarro, Laudina Rodriguez, Bethany Van Guelpen, Richard Palmqvist, Jonas Manjer, Ulrika C Ericson, Sheila A Bingham, Kay-Tee Khaw, Teresa Norat, Elio Riboli, O. Thorlacius-Ussing

Research output: Contribution to journal › Journal article › Research › peer-review

Abstract

BACKGROUND: Among the B-vitamins, folate has been studied in greatest detail in relation to colorectal cancer (CRC) risk. Although B-vitamins other than folate are also essential for one-carbon metabolism, epidemiological studies on plasma vitamins B2, B6, and B12 and CRC risk are small and inconclusive. METHODS: In this nested case-control study within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort, 1365 incident CRC cases were matched to 2319 controls for study center, age, and sex. We measured the sum of the B2 species riboflavin and flavin mononucleotide, and the sum of the B6 species pyridoxal 5'-phosphate, pyridoxal, and 4-pyridoxic acid as indicators for vitamin B2 and B6 status, as well as vitamin B12 in plasma samples collected at baseline. In addition, we determined eight polymorphisms related to one-carbon metabolism. Relative risks (RRs) for CRC were estimated with conditional logistic regression and adjusted for smoking status, education, physical activity, BMI, alcohol consumption, and intake of fiber and red and processed meat. RESULTS: Adjusted RRs comparing the highest to lowest quintile (95% confidence interval, Ptrend) were: 0.71 (0.56-0.91, 0.02) for vitamin B2, 0.68 (0.53-0.87, <0.001) for vitamin B6, and 1.02 (0.80-1.29, 0.19) for vitamin B12. The associations for vitamin B6 were stronger in males who consumed >/=30g alcohol/day. The polymorphisms were not associated with CRC. CONCLUSIONS: Results from this large European cohort study show that higher plasma concentrations of vitamins B2 and B6 are associated with a lower CRC risk.
Original languageEnglish
JournalCancer Epidemiology, Biomarkers & Prevention
Volume19
Pages (from-to)2549-2561
ISSN1055-9965
DOIs
Publication statusPublished - 2010
Externally publishedYes

Fingerprint

Dive into the research topics of 'Plasma vitamins B2, B6, B12, and related genetic variants as predictors of colorectal cancer risk'. Together they form a unique fingerprint.

Cite this